Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency

Leng, Lizhi; Tan, Yueqiu; Gong, Fei; Hu, Liang; Ouyang, Qi; Zhao, Yan; Lu, Guangxiu; Lin, Ge
March 2015
Human Reproduction;Mar2015, Vol. 30 Issue 3, p737
Academic Journal
STUDY QUESTION Can the induced pluripotent stem cells (iPSCs) derived from women with primary ovarian insufficiency (POI) differentiate into germ cells for potential disease modeling in vitro? SUMMARY ANSWER The iPSC lines derived from POI patients with 46, X, del(X)(q26) or 46, X, del(X)(q26)9qh+ could differentiate into germ cells and expressed lower levels of genes in the deletion region of the X chromosome. WHAT IS KNOWN ALREADY iPSC technology has been envisioned as an approach for generating patient-specific stem cells for disease modeling and for developing novel therapies. It has also been confirmed that iPSCs differentiate into germ cells. STUDY DESIGN, SIZE, DURATION We compared the differentiation ability of germ cells and the gene expression level of germ cell-related genes in the X chromosome deletion region of iPSC lines derived from POI patients (n = 2) with an iPSC line derived from normal fibroblasts (n = 1). PARTICIPANTS/MATERIALS, SETTING, METHODS We established three iPSC lines from two patients with partial Xq deletion-induced POI and normal fibroblasts by overexpressing four factors: octamer-binding transcription factor 4 (OCT4), sex-determining region Y-box 2 (SOX2), Nanog homeobox (NANOG), and lin-28 homolog (LIN28), using lentiviral vectors. We then generated stable-transfected fluorescent reporter cell lines under the control of the Asp-Glu-Ala-Asp box polypeptide 4 (DDX4, also called VASA) promoter, and selected clonal derived sublines. We induced subline differentiation into germ cells by adding Wnt3a (30 ng/ml) and bone morphogenetic protein 4 (100 ng/ml). After 12 days of differentiation, green fluorescent protein (GFP)-positive and GFP-negative cells were isolated via fluorescence-activated cell sorting and analyzed for endogenous VASA protein (immunostaining) and for germ cell markers and genes expressed in the deleted region of the X chromosome (quantitative RT–PCR). MAIN RESULTS AND THE ROLE OF CHANCE The POI- and normal fibroblast-derived iPSCs had typical self-renewal and pluripotency characteristics. After stable transfection with the VASA-GFP construct, the sublines POI1-iPS-V.1, POI2-iPS-V.1 and hEF-iPS-V.1 produced green fluorescent cells in the differentiated cultures, and the percentage of GFP-positive cells increased over the 12 days of differentiation to a maximum of 6.9 ± 0.33%, 5.3 ± 0.57% and 8.5 ± 0.29%, respectively, of the total cell population. Immunohistochemical analysis confirmed that endogenous VASA was enriched in the GFP-positive cells. Quantitative reverse transcription-PCR revealed significantly higher expression of germ cell markers [PR domain containing 1, with ZNF domain (PRDM1, BLIMP1), developmental pluripotency-associated 3 (DPPA3, STELLA), deleted in azoospermia-like (DAZL), and VASA (DDX4)] in GFP-positive cells than in GFP-negative cells. Moreover, the GFP-positive cells from POI-iPSCs had reduced expression of the family with sequence similarity 122C (FAM122C), inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG), and RNA binding motif protein, X-linked (RBMX), genes located in the deleted region of the X chromosome and that are highly expressed in differentiated germ cells, compared with cells from normal iPSCs. LIMITATIONS, REASONS FOR CAUTION Gene expression profiling indicated that the germ cells differentiated from POI-iPSCs were pre-meiotic. Therefore, how the differentiated primordial germ cells could progress further to meiosis and form follicles remains to be determined in the study of POI. WIDER IMPLICATIONS OF THE FINDINGS Our results might provide an in vitro model for studying germ cell development in patients with POI. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by grants from the Major State Basic ...


Related Articles

  • Derivation of iPSCs in stirred suspension bioreactors. Shafa, Mehdi; Day, Brad; Yamashita, Akihiro; Meng, Guoliang; Liu, Shiying; Krawetz, Roman; Rancourt, Derrick E // Nature Methods;May2012, Vol. 9 Issue 5, p465 

    Induced pluripotent stem cells (iPSCs) are typically derived in adherent culture. Here we report fast and efficient derivation of mouse iPSCs in stirred suspension bioreactors, with and without the use of c-Myc. Suspension-reprogrammed cells expressed pluripotency markers, showed multilineage...

  • X Chromosomes Reactivate in iPSC Lines.  // BioWorld Today;5/14/2012, Vol. 23 Issue 93, Special section p2 

    The article focuses on a study by researchers from Harvard University which revealed that X chromosomes reactivate in induced pluripotent stem (iPSC) cell lines.

  • Mice born from eggs built in the lab. Hamzelou, Jessica // New Scientist;10/13/2012, Vol. 216 Issue 2886, p15 

    The article looks at research published in "Science" on induced pluripotent stem cells (iPSCs) by scientist Katsuhiko Hayashi et al. The researchers engineered mouse iPSCs and embryonic stem cells to form cells similar to primordial germ cells (PGCs), which formed immature eggs when placed in...

  • A Time Course Analysis of the Electrophysiological Properties of Neurons Differentiated from Human Induced Pluripotent Stem Cells (iPSCs). Prè, Deborah; Nestor, Michael W.; Sproul, Andrew A.; Jacob, Samson; Koppensteiner, Peter; Chinchalongporn, Vorapin; Zimmer, Matthew; Yamamoto, Ai; Noggle, Scott A.; Arancio, Ottavio // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Many protocols have been designed to differentiate human embryonic stem cells (ESCs) and human induced pluripotent stem cells (iPSCs) into neurons. Despite the relevance of electrophysiological properties for proper neuronal function, little is known about the evolution over time of important...

  • Reproductive biology: Stem cells bear eggs. Cheloufi, Sihem; Hochedlinger, Konrad // Nature;11/22/2012, Vol. 491 Issue 7425, p535 

    The article reports on the results of a study on the development of cultured embryonic stem cells into eggs. It notes that cultured embryonic stem (ES) cells and induced pluripotent stem (iPS) cells were coaxed by researchers to develop into eggs and then to normal offspring through a process of...

  • Reprogramming in suspension. Chen, Jiekai; Pei, Duanqing // Nature Methods;May2012, Vol. 9 Issue 5, p449 

    The article discusses studies related to reprogramming of the induced pluripotent stem cells (iPSCs) of mouse in suspension culture by reprogramming. It says that both D.A. Fluri and M. Shafa and their colleagues showed that iPSCs can contribute to multiple tissues in chimeric mice, germline,...

  • Induced pluripotent stem cells in reproductive medicine. Teramura, Takeshi; Frampton, John // Reproductive Medicine & Biology;Apr2013, Vol. 12 Issue 2, p39 

    Despite recent advances in reproductive medicine, there are still no effective treatments for severe infertility caused by congenital absence of germ cells or gonadotoxic treatments during prepubertal childhood. However, the development of technologies for germ cell formation from stem cells in...

  • The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Ayyash, Muneef; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Amann-Zalcenstein, Daniela; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Canaani, Eli; Horn-Saban, Shirley; Amit, Ido; Novershtern, Noa; Hanna, Jacob H. // Nature;8/16/2012, Vol. 488 Issue 7411, p409 

    Induced pluripotent stem cells (iPSCs) can be derived from somatic cells by ectopic expression of different transcription factors, classically Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc (abbreviated as OSKM). This process is accompanied by genome-wide epigenetic changes, but how these...

  • Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications. Tao, Hongyan; Han, Zhibo; Han, Zhong Chao; Li, Zongjin // Stem Cells International;1/6/2016, p1 

    Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of cardiovascular diseases owing to their low immunogenicity, ease of isolation and expansion, and multipotency. As multipotent progenitors, MSCs have revealed their ability to differentiate into various cell types...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics